| Name | Title | Contact Details |
|---|
Medifacts International, Inc. is a Rockville, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Sun Healthcare Group, Inc. and its subsidiaries provide health care services primarily for senior population in the United States. It operates skilled nursing centers, which offer daily nursing, therapeutic rehabilitation, social, housekeeping, nutrition, and administrative services for individuals requiring certain assistance for activities in daily living. The company also operates assisted living centers that provide minimal nursing assistance, housekeeping, nutrition, laundry, and administrative services for individuals requiring minimal assistance for activities in daily living; and independent living centers, which offer security, housekeeping, nutrition, and limited laundry services for individuals requiring no assistance for activities in daily living. In addition, it operates mental health centers, which provide inpatient and outpatient behavioral health services for adults and children, as well as offers hospice services, including palliative care, social services, pain management, and spiritual counseling in 11 states. Further, the company offers rehabilitation therapy services, including speech pathology, physical therapy, and occupational therapy. Additionally, it offers temporary medical staffing comprising licensed therapists in the areas of physical, occupational, and speech therapy; nurses; pharmacists, pharmacist technicians, and medical imaging technicians physicians; and related medical personnel for hospitals and other providers, skilled nursing centers, schools, and prisons in 40 states. The company was founded in 1989 and is based in Irvine, California. As of December 3, 2012, Sun Healthcare Group, Inc. operates as a subsidiary of Genesis HealthCare LLC.
VTI Corp. is a Hialeah, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Center for Biomedical Continuing Education is a Irving, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Xenon Pharmaceuticals (NASDAQ:XENE) – a biopharmaceutical company with operations in Vancouver, BC, Canada and Boston, MA, U.S.A. – is committed to delivering innovative medicines to provide a brighter future for patients suffering from neurological disorders. At Xenon, we are advancing an exciting pipeline of neurology-focused therapies, with a particular emphasis on novel treatments for both adult and pediatric patients with epilepsy. XEN496 is currently being evaluated in the Phase 3 “EPIK” clinical trial in young patients with KCNQ2-DEE, a rare and severe form of childhood epilepsy. Late-stage development plans are also underway for our XEN1101 program, building upon the compelling data from the Phase 2b “X-TOLE” study in adult patients with focal epilepsy. We are also proud of the leading-edge science coming out of our discovery labs, with many early-stage research programs underway. In addition to Xenon`s proprietary programs, we have ongoing collaborations with our valued pharmaceutical partners. With a healthy balance sheet to support our growth plans, we continue to build a fully-integrated, premier neuroscience company with strong discovery, development, and commercial operations. Our employees are smart, passionate, dedicated, and driven by their incredibly important work to discover, develop, and deliver new medicines for patients in need. Building and maintaining a respectful, collaborative, inclusive, and productive culture is a priority for us. We are looking for great people who thrive in a fast-paced, dynamic work environment to join our team during this transformative time for Xenon.